Pharmaceuticals Companies By Net Asset

LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Net Asset
Return On Equity
Return On Asset
Profit Margin
Operating Margin
Current Valuation
Shares Outstanding
Shares Owned By Insiders
Shares Owned By Institutions
Number Of Shares Shorted
Price To Earning
Price To Book
Price To Sales
Revenue
Gross Profit
EBITDA
Net Income
Cash And Equivalents
Cash Per Share
Total Debt
Debt To Equity
Current Ratio
Book Value Per Share
Cash Flow From Operations
Short Ratio
Earnings Per Share
Price To Earnings To Growth
Target Price
Number Of Employees
Beta
Market Capitalization
Total Asset
Retained Earnings
Working Capital
Current Asset
Current Liabilities
Net AssetEfficiencyMarket RiskExp Return
1TAK Takeda Pharmaceutical Co
15.11 T
 0.00 
 1.49 
 0.00 
2RDY Dr Reddys Laboratories
492.99 B
 0.10 
 1.87 
 0.18 
3NVO Novo Nordisk AS
465.8 B
 0.01 
 3.02 
 0.04 
4PFE Pfizer Inc
213.4 B
(0.05)
 1.91 
(0.10)
5JNJ Johnson Johnson
180.1 B
(0.06)
 1.60 
(0.10)
6SNY Sanofi ADR
132.8 B
(0.09)
 1.87 
(0.17)
7MRK Merck Company
117.11 B
(0.09)
 2.25 
(0.20)
8AZN AstraZeneca PLC ADR
104.03 B
(0.03)
 1.88 
(0.06)
9NVS Novartis AG ADR
102.25 B
 0.05 
 1.55 
 0.08 
10BMY Bristol Myers Squibb
92.6 B
(0.19)
 2.07 
(0.39)
11LLY Eli Lilly and
78.71 B
(0.03)
 3.30 
(0.10)
12GSK GlaxoSmithKline PLC ADR
59.46 B
 0.02 
 2.00 
 0.04 
13VTRS Viatris
41.5 B
(0.01)
 2.60 
(0.04)
14TEVA Teva Pharma Industries
39.33 B
 0.04 
 3.23 
 0.13 
15BHC Bausch Health Companies
26.52 B
(0.04)
 4.45 
(0.16)
16RPRX Royalty Pharma Plc
18.22 B
 0.05 
 1.71 
 0.08 
17ZTS Zoetis Inc
14.24 B
(0.03)
 2.12 
(0.05)
18OGN Organon Co
13.1 B
(0.11)
 5.21 
(0.56)
19ELAN Elanco Animal Health
12.61 B
 0.10 
 4.75 
 0.46 
20JAZZ Jazz Pharmaceuticals PLC
12.01 B
(0.13)
 3.03 
(0.40)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund. Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY